NCT02276898View on ClinicalTrials.gov

A Randomized-Controlled Trial of Inhaled Hypertonic Saline (7%) to Evaluate the Lung Clearance Index

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Cystic Fibrosis
Interventions
DRUG

Hypertonic Saline 7%

PARI Hyper-Sal™ Sodium Chloride Solution - 7%

DRUG

Isotonic Saline 0.9% (Placebo)

Trial Locations (2)

M5V1X8

The Hospital for Sick Children, Toronto

Unknown

St. Michaels Hospital, Toronto

All Listed Sponsors
lead

The Hospital for Sick Children

OTHER

NCT02276898 - A Randomized-Controlled Trial of Inhaled Hypertonic Saline (7%) to Evaluate the Lung Clearance Index | Biotech Hunter | Biotech Hunter